Skip to main content
OpenTrials

Clinical trial condition

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma

Explore clinical trials studying Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma trial results

Completed

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

NCT02900664

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +31 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center SC-3 Baltimore, Maryland, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details

Related conditions